| Withdrawn | Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 3 NCT04598516 | Maastricht University Medical Center | — |
| Withdrawn | Time to Excretion of Contrast, a Maastricht Prospective Observational Study NCT04603261 | Maastricht University Medical Center | — |
| Withdrawn | Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast NCT04597892 | Maastricht University Medical Center | — |
| Not Yet Recruiting | Role of Amlodipine in Reduction of CIN NCT07291375 | Minia University | EARLY_Phase 1 |
| Recruiting | Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED NCT07459413 | Gaziosmanpasa Research and Education Hospital | N/A |
| Recruiting | Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acut NCT06695429 | Hospital General Universitario Santa Lucia | N/A |
| Unknown | Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients. NCT06429345 | Ain Shams University | Phase 4 |
| Completed | Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography NCT07184918 | Tanta University | N/A |
| Active Not Recruiting | Contrast Nephropathy Associated FFA NCT06418542 | Saglik Bilimleri Universitesi | Phase 4 |
| Active Not Recruiting | Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans NCT04606056 | Changi General Hospital | — |
| Unknown | Predictive Value of Osteopontin for Contrast Nephropathy NCT05547581 | Noura gamal | — |
| Recruiting | Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contr NCT05283512 | Odense University Hospital | N/A |
| Withdrawn | Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Cor NCT04627831 | Ligand Pharmaceuticals | Phase 2 |
| Recruiting | Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial NCT04982419 | VA Office of Research and Development | Phase 2 / Phase 3 |
| Active Not Recruiting | Clinical Validation of the RENISCHEM L-FABP POC Assay NCT04864847 | Hikari Dx, Inc. | — |
| Terminated | Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury NCT04877847 | Sonogenix | N/A |
| Unknown | Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography NCT05271448 | An-Najah National University | N/A |
| Completed | Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients NCT05264584 | Ain Shams University | N/A |
| Completed | Effect of Hydration Guided by Vigileo on the Prevention of CIN After PCI for Patients With AMI NCT04382313 | Chinese PLA General Hospital | N/A |
| Withdrawn | Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary NCT03806725 | Stanford University | — |
| Unknown | Metformin in Diabetic Patients Undergoing Coronary Angiography NCT04766008 | Humanitas Hospital, Italy | Phase 4 |
| Completed | Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization NCT04266834 | Qure Healthcare, LLC | N/A |
| Completed | Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography NCT04163250 | Eva de Miguel Balsa | — |
| Completed | Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection NCT03869983 | CyDex Pharmaceuticals, Inc. | N/A |
| Completed | Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease NCT04163484 | I.M. Sechenov First Moscow State Medical University | — |
| Unknown | Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) NCT03767322 | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 2 |
| Completed | Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30 NCT04592406 | Maastricht University Medical Center | — |
| Completed | The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy NCT03627130 | Barts & The London NHS Trust | Phase 2 |
| Unknown | Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Cor NCT03736018 | Queen Mary University of London | N/A |
| Completed | Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in B NCT07022626 | Barts & The London NHS Trust | N/A |
| Unknown | Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Cathe NCT03755700 | Rajaie Cardiovascular Medical and Research Center | Phase 3 |
| Completed | Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis NCT03731962 | Shahid Beheshti University of Medical Sciences | N/A |
| Completed | Proenkephalin for Prediction of Contrast-Associated Kidney Events NCT03989505 | Dr. med. Mahir Karakas | — |
| Completed | Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization NCT03305874 | University of Chicago | — |
| Completed | Remote Ischemic Preconditioning for Renal Protection in TAVI NCT03347032 | Henry Ford Health System | N/A |
| Completed | Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy NCT03391830 | Mansoura University | N/A |
| Unknown | Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran NCT03266458 | Assiut University | — |
| Unknown | Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Interv NCT03164681 | Assiut University | — |
| Completed | The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography NCT03329443 | Alhasan Mujtaba Abdul-Wahid | Phase 2 |
| Unknown | Investigation of Relationship Between Contrast Nephropathy and Caval Index Measurement in Patients With Ileus NCT03261518 | Derince Training and Research Hospital | — |
| Unknown | Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department NCT03238391 | Derince Training and Research Hospital | N/A |
| Terminated | Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT NCT03116139 | Indiana University | N/A |
| Completed | Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold NCT03227835 | Maastricht University Medical Center | — |
| Unknown | Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement NCT03121053 | St. Antonius Hospital | Phase 4 |
| Completed | Remote Ischemic Preconditioning as a Method Against Subclinical Renal Injury and Contrast-induced Nephropathy NCT02700958 | Tartu University Hospital | N/A |
| Completed | Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy. NCT03867994 | rabab ahmed mohamed | Phase 2 |
| Completed | Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study NCT02669784 | Milton S. Hershey Medical Center | N/A |
| Withdrawn | Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropa NCT03136458 | Camilo Andrés Páez Angarita | N/A |
| Unknown | Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy NCT02489240 | Chinese PLA General Hospital | N/A |
| Unknown | Contrast Induced Nephropathy Among Vascular Patients Undergoing Lower Limb Angioplasty NCT04879186 | Singapore General Hospital | — |
| Completed | Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy NCT04225013 | R. Laura Vicente Vicente | — |
| Terminated | Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomogr NCT02440646 | Central Clinical Hospital of the Russian Academy of Sciences | — |
| Completed | Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy NCT02516072 | Changi General Hospital | N/A |
| Completed | A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effe NCT02106234 | Maastricht University Medical Center | N/A |
| Completed | Metabolic Syndrome and Contrast Induced Nephropathy NCT02192372 | Ankara University | — |
| Completed | Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial NCT02650336 | Sun Yat-sen University | — |
| Unknown | Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropa NCT02088502 | Isfahan University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | High Dose Atorvastatin for Preventing Contrast-induced Nephropathy NCT02114346 | Isfahan University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Contrast Nephropathy and Nitrates NCT01999517 | Mt. Sinai Medical Center, Miami | Phase 4 |
| Unknown | Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction NCT01871792 | Gachon University Gil Medical Center | Phase 4 |
| Unknown | REduction of rIsk for Contrast Induced Nephropathy NCT01402232 | Guangdong Provincial People's Hospital | — |
| Withdrawn | Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography NCT01144091 | Meir Medical Center | N/A |
| Completed | Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Co NCT01741896 | Mid Western Regional Hospital, Ireland | N/A |
| Completed | CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better? NCT04014153 | I.M. Sechenov First Moscow State Medical University | — |
| Unknown | Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography NCT02113540 | Isfahan University of Medical Sciences | Phase 3 |
| Unknown | Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients NCT01456013 | CardioRenal Systems, Inc. | Phase 3 |
| Completed | Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI NCT05132062 | Icahn School of Medicine at Mount Sinai | — |
| Completed | PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio NCT01400295 | Guangdong Provincial People's Hospital | — |
| Completed | Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction NCT01160627 | Odense University Hospital | N/A |
| Unknown | Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Pa NCT01061320 | Thammasat University | Phase 3 |
| Unknown | Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention NCT01399203 | Guangdong Provincial People's Hospital | — |
| Unknown | Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients NCT01017796 | University of Thessaly | EARLY_Phase 1 |
| Completed | Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (A NCT00827788 | Ospedale San Donato | Phase 4 |
| Completed | The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases NCT00842868 | Massachusetts General Hospital | — |
| Unknown | Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) NCT00702728 | Centro Cardiologico Monzino | Phase 3 |
| Unknown | Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography NCT00950079 | CardioVascular Research Foundation, Korea | Phase 4 |
| Terminated | Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Fa NCT00575419 | Oregon Health and Science University | Phase 1 |
| Completed | Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy NCT00634491 | Shiraz University of Medical Sciences | Phase 2 |
| Completed | Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontr NCT00513825 | Tehran University of Medical Sciences | Phase 2 |
| Completed | Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN) NCT00514150 | Tehran University of Medical Sciences | Phase 3 |
| Completed | COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT NCT00497328 | National University Hospital, Singapore | Phase 2 / Phase 3 |
| Terminated | The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy NCT00494637 | Lenox Hill Hospital | N/A |
| Completed | Sodium Bicarbonate in Preventing Contrast Induced Nephropathy NCT00531765 | King Faisal Specialist Hospital & Research Center | N/A |
| Completed | Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction. NCT00639912 | Azienda USL Reggio Emilia - IRCCS | Phase 4 |
| Completed | Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients NCT00467311 | National Heart Institute, Mexico | — |
| Unknown | Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate NCT00392405 | Norton Community Hospital | Phase 2 |
| Completed | Statins for Prevention of Contrast Induced Nephropathy NCT00770796 | Ospedale Misericordia e Dolce | Phase 4 |
| Completed | Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate NCT00312117 | Kaiser Permanente | Phase 3 |
| Withdrawn | Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy NCT01093131 | The Western Pennsylvania Hospital | Phase 4 |
| Completed | Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy NCT00606827 | Ospedale Misericordia e Dolce | Phase 4 |
| Completed | Patients With Renal Impairment Undergoing CT NCT00292487 | Bracco Diagnostics, Inc | Phase 4 |
| Terminated | Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial NCT00476619 | Brigham and Women's Hospital | Phase 4 |
| Completed | Hydration and Contrast-Induced Nephropathy in Primary Angioplasty NCT00770614 | Ospedale Misericordia e Dolce | Phase 4 |
| Completed | Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction NCT00237614 | University of Milan | Phase 2 / Phase 3 |
| Completed | N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography NCT00830193 | Unity Health Toronto | Phase 2 / Phase 3 |
| Completed | Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy NCT00492518 | Technical University of Munich | Phase 4 |
| Completed | Prevention of Contrast-Induced Nephropathy NCT00175227 | University of Alberta | N/A |
| Withdrawn | Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN) NCT00749827 | Memorial University of Newfoundland | Phase 4 |